Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
+myBinderRelated Content
-
Carolyn C. Hoppe, MDDr. Hoppe is a senior clinician and scie...
-
Jeffrey Lebensburger, MDDr. Lebensburger is a graduate of the Un...
-
Sickle cell pain in the emergency departmentSickle cell disease is characterized by ...
-
Implementation of a social worker screening process to explore unmet psychological and social needs for adults with ...The most common symptom for persons with...
-
Cincinnati Children’s Hospital Medical CenterThe Comprehensive Sickle Cell Center at ...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Sickle Cell Disease: Data Saves Lives“One minute I’d be fine, the next mi...
